American Thyroid Association Satellite Symposium: The Spectrum of Thyroid Cancer, From Surveillance to Systemic Therapy
American Thyroid Association Satellite Symposium: The Spectrum of Thyroid Cancer, From Surveillance to Systemic Therapy
PLEASE REGISTER THEN CLICK "START" TO EVALUATE SESSIONS, CLAIM CME, AND PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION.
Target Audience
This continuing medical education activity should be of substantial interest to the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, trainees, nurses, physician assistants, other health care professionals and the general public who wish to broaden and update their knowledge on hypothyroidism.
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Understand how the therapy of hypothyroidism has evolved since the first use of thyroid gland preparations
- Describe how TSH references intervals may vary for different populations and understand the impact of TSH values on outcomes, morbidity, and mortality
- List the factors other than serum TSH values, such as T3 levels and polymorphisms in TH transporters and deiodinases, that may potentially provide information about the thyroid status of patients
- Describe the potential benefits and risks of combination therapy, and weigh these factors in order to determine whether combination therapy should be offered to patients with hypothyroidism
- Review areas with significant knowledge gaps, such as whether measuring additional thyroid analytes beyond TSH and FT4 is helpful, and whether diet/dietary supplements impact thyroid function
- Describe how patient-centered outcomes might be incorporated into the management of patients with hypothyroidism
- Appreciate the patient perspective during the treatment of hypothyroidism
Additional Information
Douglas Van Nostrand, MD
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The ATA Guidelines Satellite Symposium faculty reported relevant financial relationship(s):
Thomas J. Giordano, MD, PhD: Consultant, Rosetta Genomics
Manisha H. Shah, MD: Consulting, LOXO, Novartis; Primary Investigator, Merck, LOXO, Eisai
R. Michael Tuttle, MD: Consultant, Eisai, Genzyme, Sanofi, Bayer
The ATA Guidelines Satellite Symposium faculty reported no relevant financial relationship(s) during the content development process for this activity:
Charles H. Emerson, MD, Douglas Van Nostrand, MD, Mona M. Sabra, MD, Mara Yvonne Roth, MD, Wendy Sacks, MD, Carmen C. Solorzano, MD, Lilah F. Morris-Wiseman
The ATA Guidelines Satellite Symposium Program Committee member reported no relevant financial relationship (s):
James D. Brierley, Lori J. Wirth, MD
The following Endocrine Society Special Programs Committee member who reviewed content for this activity reported financial relationships:
Giuseppe Barbesino, MD: Spouse, employee of Genzyme
The following SPC members reported no relevant financial relationships:
Amy Rothberg, MD, Susmeeta Sharma, MD
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical ed ucation for physicians.
The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™ and 4.25 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Review your ABIM Diplomate ID Number(s)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM) or American Board of Pediatrics (ABP), you must:
- Provide your board-certification information in your educational profile. Your profile currently contains the following board ID numbers (must be logged in to view):
Your ABIM Number: [current-user:profile-profile:field-number-abim]*
*If your ABP or ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
Available Credit
- 4.25 ABIM MOC
- 4.25 AMA PRA Category 1 Credits™
- 4.25 CME Certificate of Participation